Abstract
Cancer represents one of the most fatal health issues, claiming the lives of millions of people each year. Tumorous growths can develop in almost any portion of the body and migrate to different parts. There are numerous treatment approaches available for cancer such as radiation therapy, photodynamic therapy, and cancer vaccinations. However, in most cases, they have adverse side effects. Thus, anticancer medications with higher efficiency and fewer side effects are desperately needed. Plants are a prospective source of such compounds. Natural plant bioactive substances have been used in traditional medicine since the dawn of humanity. These metabolites have also been implicated in providing protection to plants under various environmental influences, such as the influence of UV-B. Plant-based natural secondary metabolites/phytochemicals and their derivatives have great potential in the suppression of cancer development and metastasis. These biologically active compounds can be isolated from various plant parts, such as leaves, stems, barks, flowers, rhizomes, roots, and seeds. The natural bioactive compounds produced by plants during secondary metabolism have great pharmacological importance, especially as anticancer agents. Therefore, this chapter is an attempt to summarize the importance of various plant-derived compounds and their mechanism of action, which can be used in cancer therapies as anticancer agents.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Bakshi H, Sam S, Rozati R, Sultan P, Islam T, Rathore B, Lone Z, Sharma M, Triphati J, Saxena RC (2010) DNA fragmentation and cell cycle arrest: a hallmark of apoptosis induced by crocin from Kashmiri saffron in a human pancreatic cancer cell line. Asian Pac J Cancer Prev 11(3):675–679
Balachandran P, Govindarajan R (2005) Cancer—an ayurvedic perspective. Pharmacol Res 51(1):19–30
Barreca M, Spanò V, Raimondi MV, Tarantelli C, Spriano F, Bertoni F, Barraja P, Montalbano A (2021) Recurrence of the oxazole motif in tubulin colchicine site inhibitors with anti-tumor activity. Eur J Med Chem Rep 1:100004
Bennett JW, Bentley R (1989) What’s in a name?—microbial secondary metabolism. Adv Appl Microbiol 34:1–28
Bernard MM, McConnery JR, Hoskin DW (2017) [10]-Gingerol, a major phenolic constituent of ginger root, induces cell cycle arrest and apoptosis in triple-negative breast cancer cells. Exp Mol Pathol 102(2):370–376
Bhandari M, Ravipati AS, Reddy N, Koyyalamudi SR (2015) Traditional ayurvedic medicines: pathway to develop anti-cancer drugs. J Mol Pharm Organ Process Res
Cencic R, Carrier M, Galicia-Vázquez G, Bordeleau ME, Sukarieh R, Bourdeau A, Brem B, Teodoro JG, Greger H, Tremblay ML, Porco JA Jr (2009) Antitumor activity and mechanism of action of the cyclopenta [b] benzofuran, silvestrol. PLoS One 4(4):e5223
Chaudhary A, Pandeya SN, Kumar P, Sharma PP, Gupta S, Soni N, Verma KK, Bhardwaj G (2007) Combretastatin A-4 analogs as anticancer agents. Mini Rev Med Chem 7(12):1186–1205
Constantinou C, Papas A, Constantinou AI (2008) Vitamin E and cancer: an insight into the anticancer activities of vitamin E isomers and analogs. Int J Cancer 123(4):739–752
Coutinho EM (2002) Gossypol: a contraceptive for men. Contraception 65(4):259–263
Creemers GJ, Bolis G, Gore M, Scarfone G, Lacave AJ, Guastalla JP, Despax R, Favalli G, Kreinberg R, Van Belle S, Hudson I (1996) Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: results of a large European phase II study. J Clin Oncol 14(12):3056–3061
Dai SX, Li WX, Han FF, Guo YC, Zheng JJ, Liu JQ, Wang Q, Gao YD, Li GH, Huang JF (2016) In silico identification of anti-cancer compounds and plants from traditional Chinese medicine database. Sci Rep 6(1):1–11
Das T, Anand U, Pandey SK, Ashby CR Jr, Assaraf YG, Chen ZS, Dey A (2021) Therapeutic strategies to overcome taxane resistance in cancer. Drug Resist Updat 55:100754
Ekor M (2014) The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol 4:177
Enzell CR (1969) Mass spectrometric studies of carotenoids. Pure Appl Chem 20(4):497–516
Fridlender M, Kapulnik Y, Koltai H (2015) Plant derived substances with anti-cancer activity: from folklore to practice. Front Plant Sci 6:799
Gaba S, Saini A, Singh G, Monga V (2021) An insight into the medicinal attributes of berberine derivatives: a review. Bioorg Med Chem 38:116143
Gordaliza M, Garcıa PA, Del Corral JM, Castro MA, Gómez-Zurita MA (2004) Podophyllotoxin: distribution, sources, applications and new cytotoxic derivatives. Toxicon 44(4):441–459
Gutheil WG, Reed G, Ray A, Anant S, Dhar A (2012) Crocetin: an agent derived from saffron for prevention and therapy for cancer. Curr Pharm Biotechnol 13(1):173–179
Habtemariam S, Lentini G (2018) Plant-derived anticancer agents: lessons from the pharmacology of geniposide and its aglycone, genipin. Biomedicine 6(2):39
Harborne JB (1999) Classes and functions of secondary products from plants. Chem Plants 26:1–25
Kamal-Eldin A, Appelqvist LÅ (1996) The chemistry and antioxidant properties of tocopherols and tocotrienols. Lipids 31(7):671–701
Khan N, Syed DN, Ahmad N, Mukhtar H (2013) Fisetin: a dietary antioxidant for health promotion. Antioxid Redox Signal 19(2):151–162
Kim MJ, Kim H (2015) Anticancer effect of lycopene in gastric carcinogenesis. J Cancer Prev 20(2):92
Kim S, Hwang BY, Su BN, Chai H, Mi Q, Kinghorn AD, Wild R, Swanson SM (2007) Silvestrol, a potential anticancer rocaglate derivative from Aglaia foveolata, induces apoptosis in LNCaP cells through the mitochondrial/apoptosome pathway without activation of executioner caspase-3 or-7. Anticancer Res 27(4B):2175–2183
Kim SH, Kaplan JA, Sun Y, Shieh A, Sun HL, Croce CM, Grinstaff MW, Parquette JR (2015) The self-assembly of anticancer camptothecin-dipeptide nanotubes: a minimalistic and high drug loading approach to increased efficacy. Chemistry 21(1):101–105
Kimira M, Arai Y, Shimoi K, Watanabe S (1998) Japanese intake of flavonoids and isoflavonoids from foods. J Epidemiol 8(3):168–175
Kovalchuk O, Kovalchuk I (2020) Cannabinoids as anticancer therapeutic agents. Cell Cycle 19(9):961–989
Kumar A, Chopra K, Mukherjee M, Pottabathini R, Dhull DK (2015) Current knowledge and pharmacological profile of berberine: an update. Eur J Pharmacol 761:288–297
Kumar A, Sharma PR, Mondhe DM (2017) Potential anticancer role of colchicine-based derivatives: an overview. Anti-Cancer Drugs 28(3):250–262
Lo CY, Hsu LC, Chen MS, Lin YJ, Chen LG, Kuo CD, Wu JY (2013) Synthesis and anticancer activity of a novel series of 9-O-substituted berberine derivatives: a lipophilic substitute role. Bioorg Med Chem Lett 23(1):305–309
Mangal N, Erridge S, Habib N, Sadanandam A, Reebye V, Sodergren MH (2021) Cannabinoids in the landscape of cancer. J Cancer Res Clin Oncol 147(9):2507–2534
Marzocco S, Singla RK, Capasso A (2021) Multifaceted effects of lycopene: a boulevard to the multitarget-based treatment for cancer. Molecules 26(17):5333
Nafees S, Zafaryab M, Mehdi SH, Zia B, Rizvi MA, Khan MA (2021) Anti-cancer effect of gingerol in cancer prevention and treatment. Anticancer Agents Med Chem 21(4):428–432
Nakhjavani M, Palethorpe HM, Tomita Y, Smith E, Price TJ, Yool AJ et al (2019) Stereoselective anti-cancer activities of ginsenoside Rg3 on triple negative breast cancer cell models. Pharmaceuticals 12(3):117
Nirmala MJ, Samundeeswari A, Sankar PD (2011) Natural plant resources in anti-cancer therapy—a review. Res Plant Biol 1(3):01–14
Nozhat Z, Heydarzadeh S, Memariani Z, Ahmadi A (2021) Chemoprotective and chemosensitizing effects of apigenin on cancer therapy. Cancer Cell Int 21(1):1–26
Ozbey U, Attar R, Romero MA, Alhewairini SS, Afshar B, Sabitaliyevich UY, Hanna-Wakim L, Ozcelik B, Farooqi AA (2019) Apigenin as an effective anticancer natural product: spotlight on TRAIL, WNT/β-catenin, JAK-STAT pathways, and microRNAs. J Cell Biochem 120(2):1060–1067
Pathania S, Ramakrishnan SM, Bagler G (2015) Phytochemica: a platform to explore phytochemicals of medicinal plants. Database 2015
Peng Y, Zhang R, Yang X, Zhang Z, Kang N, Bao L et al (2019) Ginsenoside Rg3 suppresses the proliferation of prostate cancer cell line PC3 through ROS-induced cell cycle arrest. Oncol Lett 17(1):1139–1145
Petzke TL, Shi QW, Sauriol F, Mamer O, Zamir LO (2004) Taxanes from rooted cuttings of Taxus canadensis. J Nat Prod 67(11):1864–1869
Pfander H, Rychener M (1982) Separation of crocetin glycosyl esters by high-performance liquid chromatography. J Chromatogr A 234(2):443–447
Rodrigues FC, Kumar NA, Thakur G (2021) The potency of heterocyclic curcumin analogues: an evidence-based review. Pharmacol Res 166:105489
Roja G, Rao PS (2000) Anticancer compounds from tissue cultures of medicinal plants. J Herbs Spices Med Plants 7(2):71–102
Salim AA, Garson MJ, Craik DJ (2004) New indole alkaloids from the roots of Ochrosia acuminata. J Nat Prod 67(10):1719–1721
Salmela AL, Pouwels J, Varis A, Kukkonen AM, Toivonen P, Halonen PK, Perälä M, Kallioniemi O, Gorbsky GJ, Kallio MJ (2009) Dietary flavonoid fisetin induces a forced exit from mitosis by targeting the mitotic spindle checkpoint. Carcinogenesis 30(6):1032–1040
Shankar E, Goel A, Gupta K, Gupta S (2017) Plant flavone apigenin: an emerging anticancer agent. Curr Pharmacol Rep 3(6):423–446
Sharifi-Rad J, Ozleyen A, Boyunegmez Tumer T, Oluwaseun Adetunji C, El Omari N, Balahbib A, Taheri Y, Bouyahya A, Martorell M, Martins N, Cho WC (2019) Natural products and synthetic analogs as a source of antitumor drugs. Biomol Ther 9(11):679
Shelley MD, Hartley L, Groundwater PW, Fish RG (2000) Structure-activity studies on gossypol in tumor cell lines. Anti-Cancer Drugs 11(3):209–216
Smolarek AK, Suh N (2011) Chemopreventive activity of vitamin E in breast cancer: a focus on γ-and δ-tocopherol. Nutrients 3(11):962–986
Spencer CM, Faulds D (1994) Paclitaxel. Drugs 48(5):794–847
Stiborova M, Rupertova M, Schmeiser HH, Frei E (2006) Molecular mechanisms of antineoplastic action of an anticancer drug ellipticine. Biomed Pap Palacky Univ Olomouc 150(1):13
Sun S, Qi LW, Du GJ, Mehendale SR, Wang CZ, Yuan CS (2011) Red notoginseng: higher ginsenoside content and stronger anticancer potential than Asian and American ginseng. Food Chem 125(4):1299–1305
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249
Thomas DR, Penney CA, Majumder A, Walmsley AM (2011) Evolution of plant-made pharmaceuticals. Int J Mol Sci 12(5):3220–3236
Uesato S, Ueda S, Kobayashi K, Miyauchi M, Itoh H, Inouye H (1986) Intermediacy of 8-epiiridodial in the biosynthesis of iridoid glucosides by Gardenia jasminoides cell cultures. Phytochemistry 25(10):2309–2314
Van Wyk BE, Wink M (2018) Medicinal plants of the world. CABI
Wang CY, Bai XY, Wang CH (2014) Traditional Chinese medicine: a treasured natural resource of anticancer drug research and development. Am J Chin Med 42(03):543–559
Wang X, Zhang C, Yan X, Lan B, Wang J, Wei C, Cao X, Wang R, Yao J, Zhou T, Zhou M (2016) A novel bioavailable BH3 mimetic efficiently inhibits colon cancer via cascade effects of mitochondria. Clin Cancer Res 22(6):1445–1458
Xiao J, Gao M, Sun Z, Diao Q, Wang P, Gao F (2020) Recent advances of podophyllotoxin/epipodophyllotoxin hybrids in anticancer activity, mode of action, and structure-activity relationship: an update (2010-2020). Eur J Med Chem 208:112830
Xu J, Qi G, Wang W, Sun XS (2021) Advances in 3D peptide hydrogel models in cancer research. NPJ Sci Food 5(1):1–10
Yahyazadeh R, Baradaran Rahimi V, Yahyazadeh A, Mohajeri SA, Askari VR (2021) Promising effects of gingerol against toxins: a review article. Biofactors 47:885
Yan Z, Lai Z, Lin J (2017) Anticancer properties of traditional Chinese medicine. Comb Chem High Throughput Screen 20(5):423–429
Zahiri M, Taghdisi SM, Abnous K, Ramezani M, Alibolandi M (2021) Fabrication of versatile targeted lipopolymersomes for improved camptothecin efficacy against colon adenocarcinoma in vitro and in vivo. Expert Opin Drug Deliv 18(9):1309–1322
Zhao W, Cong Y, Li HM, Li S, Shen Y, Qi Q, Zhang Y, Li YZ, Tang YJ (2021) Challenges and potential for improving the druggability of podophyllotoxin-derived drugs in cancer chemotherapy. Nat Prod Rep 38(3):470–488
Zhao Y, Feng JH, Ding HX, Xiong Y, Cheng CH, Hao XJ et al (2006) Synthesis and cytotoxicity of racemic isodeoxypodophyllotoxin analogues with isoprene-derived side chains. J Nat Prod 69(8):1145–1152
Zhou XJ, Rahmani R (1992) Preclinical and clinical pharmacology of vinca alkaloids. Drugs 44(4):1–16
Zhu H, He YS, Ma J, Zhou J, Kong M, Wu CY, Mao Q, Lin G, Li SL (2021) The dual roles of ginsenosides in improving the anti-tumor efficiency of cyclophosphamide in mammary carcinoma mice. J Ethnopharmacol 265:113271
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Singh, S., Saha, P., Rai, N., Kumari, S., Pandey-Rai, S. (2023). Pharmacology of Natural and Synthetic Phytoprotectants: Application and Consequences in Cancer Therapies. In: Kannaujiya, V.K., Sinha, R.P., Rahman, M.A., Sundaram, S. (eds) Photoprotective Green Pharmacology: Challenges, Sources and Future Applications. Springer, Singapore. https://doi.org/10.1007/978-981-99-0749-6_11
Download citation
DOI: https://doi.org/10.1007/978-981-99-0749-6_11
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-0748-9
Online ISBN: 978-981-99-0749-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)